Darucainide (B) is a new, orally available class IBagent and was shown to be highly effective in experimental arrhythmias. We initially studied 12 pts (group A: 40-68 years, 6 men) with very frequent, repetitive and refractory (< 2 agents) ventricular premature beats (5600 VPB/h, median: 18.552 VPDs
β¦ LIBER β¦
Antiarrhythmic drugs and reperfusion
- Publisher
- Springer US
- Year
- 1991
- Tongue
- English
- Weight
- 147 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0920-3206
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Antiarrhythmic drugs and reperfusion
π
Article
π
1991
π
Springer US
π
English
β 321 KB
Antiarrhythmic drugs
β
Denis Roy
π
Article
π
1986
π
Springer-Verlag
π
French
β 221 KB
Electrophysiologic evaluation of antiarr
β
Paul Touboul
π
Article
π
1990
π
Springer US
π
English
β 365 KB
Electrophysiologic techniques are used to assess the properties of antiarrhythmic drugs and also to provide support for the selection of antiarrhythmic therapy for individual patients. Assessment of the antiarrhythmic efficacy of drugs requires that the arrhythmia can be induced by programmed electr
Comparative hemodynamics of antiarrhythm
β
Magdi Sami
π
Article
π
1990
π
Springer US
π
English
β 369 KB
It is important to consider the hemodynamic effects of antiarrhythmic drugs, because the majority of patients who require these drugs already have compromised cardiac function. The presently available antiarrhythmic agents vary in their potential for producing negative inotropic effects on the myoca
New antiarrhythmic drugs. II. Flecainide
β
Adam Schneeweiss
π
Article
π
1990
π
Springer
π
English
β 350 KB
Antiarrhythmic drug developmentβillusion
β
Michael J. A. Walker
π
Article
π
2002
π
John Wiley and Sons
π
English
β 35 KB